Pharma

Your Article Summary

See Latest Articles

New Data Highlights Advances in MS Treatment Research
Teva Pharmaceutical Industries, 09/09/09

Teva Pharmaceutical Industries Ltd. announced that new research data furthering the clinical understanding of its diverse multiple sclerosis treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, September 2009. Featured presentations and abstracts will include new data on COPAXONE, the global leading treatment for relapsing–remitting multiple sclerosis , as well as on the company's compounds in advanced development.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 32nd Annual San Antonio Breast Cancer Symposium
Cytokinetics, 12/15/09

Human genome sciences invites investors to listen to webcast of presentation at deutsche bank conference
Human Genome Sciences, 12/14/09

KLAS Ranks PACS Products
HealthDataManagement, 12/11/09

 See all of Conferences/Meetings

Today in Research & Development...keeping you current

Receive free subspecialty "5-minute updates" via email

GSK study showed targeted therapy combination achieved 14 month overall survival in patients with advanced breast cancer
GlaxoSmithKline, 12/15/09

New Phase II Study Showed Trastuzumab-DM1 Shrank Tumors in Women With Highly Advanced HER2-positive Breast Cancer
Genentech, 12/15/09

GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines
GlaxoSmithKline, 12/15/09

 See all of Research & Development